company background image
MDB logo

Medicofarma Biotech WSE:MDB Stock Report

Last Price

zł0.97

Market Cap

zł65.9m

7D

-1.8%

1Y

-6.3%

Updated

27 Mar, 2024

Data

Company Financials

MDB Stock Overview

Medicofarma Biotech SA, a biotechnology company, provides medicines, medicinal products, and biotechnology products.

MDB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Medicofarma Biotech SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medicofarma Biotech
Historical stock prices
Current Share Pricezł0.97
52 Week Highzł2.00
52 Week Lowzł0.83
Beta3.17
1 Month Change-1.62%
3 Month Change-11.42%
1 Year Change-6.28%
3 Year Change-77.75%
5 Year Change107.27%
Change since IPO-25.38%

Recent News & Updates

Recent updates

Shareholder Returns

MDBPL Life SciencesPL Market
7D-1.8%-1.8%2.3%
1Y-6.3%-17.1%35.3%

Return vs Industry: MDB exceeded the Polish Life Sciences industry which returned -16% over the past year.

Return vs Market: MDB underperformed the Polish Market which returned 35.7% over the past year.

Price Volatility

Is MDB's price volatile compared to industry and market?
MDB volatility
MDB Average Weekly Movement4.8%
Life Sciences Industry Average Movement6.3%
Market Average Movement5.0%
10% most volatile stocks in PL Market9.5%
10% least volatile stocks in PL Market3.2%

Stable Share Price: MDB has not had significant price volatility in the past 3 months.

Volatility Over Time: MDB's weekly volatility has decreased from 10% to 5% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200120Cezary Kilczewskihttps://medicofarmabiotech.pl

Medicofarma Biotech SA, a biotechnology company, provides medicines, medicinal products, and biotechnology products. The company is involved in the research and development works in collaboration with pharmaceutical and cosmetic manufacturing plants, as well as research units. It also offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics; and covid-19 test kits, such as real time PCR genetic tests.

Medicofarma Biotech SA Fundamentals Summary

How do Medicofarma Biotech's earnings and revenue compare to its market cap?
MDB fundamental statistics
Market capzł65.94m
Earnings (TTM)-zł2.67m
Revenue (TTM)zł750.81k

87.8x

P/S Ratio

-24.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDB income statement (TTM)
Revenuezł750.81k
Cost of Revenuezł914.82k
Gross Profit-zł164.01k
Other Expenseszł2.51m
Earnings-zł2.67m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 13, 2024

Earnings per share (EPS)-0.039
Gross Margin-21.84%
Net Profit Margin-355.88%
Debt/Equity Ratio0%

How did MDB perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.